The mTOR protein itself is seldom altered, suggesting that mTOR is a stable target for influencing several important pathways in cancer.[43] Furthermore, identifying these molecular defects in a tumor may provide the biomarkers that determine whether the cancer will be sensitive to mTOR inhibition and help select the most appropriate treatment strategy. The gene discussed is MTOR; the disease is neoplasm.